Literature DB >> 18567075

Risk of colorectal neoplasm in patients with acromegaly: a meta-analysis.

Theodoros Rokkas1, Dimitrios Pistiolas, Panos Sechopoulos, Georgios Margantinis, Georgios Koukoulis.   

Abstract

AIM: To examine the risk of colorectal neoplasm in acromegalic patients by meta-analyzing all relevant controlled studies.
METHODS: Extensive English language medical literature searches for human studies, up to December 2007, were performed using suitable keywords. Pooled estimates [odds ratio (OR) with 95% confidence intervals (CI)] were obtained using either the fixed or random-effects model as appropriate. Heterogeneity between studies was evaluated with the Cochran Q test whereas the likelihood of publication bias was assessed by constructing funnel plots. Their symmetry was estimated by the adjusted rank correlation test.
RESULTS: For hyperplastic polyps the pooled ORs with 95% CI were 3.557 (2.587-4.891) by fixed effects model and 3.703 (2.565-5.347) by random effects model. The Z test values for overall effect were 7.81 and 6.984, respectively (P < 0.0001). For colon adenomas the pooled ORs with 95% CI were 2.486 (1.908-3.238) (fixed effects model) and 2.537 (1.914-3.364) (random effects model). The Z test values were 6.747 and 6.472, respectively (P < 0.0001). For colon cancer the pooled OR with 95% CI was identical for both fixed and random effects model (OR, 4.351; 95% CI, 1.533-12.354; Z = 2.762, P = 0.006]. There was no significant heterogeneity and no publication bias in all the above meta-analyses.
CONCLUSION: Acromegaly is associated with an increased risk of colorectal neoplasm.

Entities:  

Mesh:

Year:  2008        PMID: 18567075      PMCID: PMC2716609          DOI: 10.3748/wjg.14.3484

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  53 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

2.  Insulin-like growth factor I and the development of colorectal neoplasia in acromegaly.

Authors:  P J Jenkins; V Frajese; A M Jones; C Camacho-Hubner; D G Lowe; P D Fairclough; S L Chew; A B Grossman; J P Monson; G M Besser
Journal:  J Clin Endocrinol Metab       Date:  2000-09       Impact factor: 5.958

3.  Clinical features and therapeutic outcomes of 65 patients with acromegaly at Tokyo Women's Medical University.

Authors:  I Fukuda; N Hizuka; Y Murakami; E Itoh; K Yasumoto; A Sata; K Takano
Journal:  Intern Med       Date:  2001-10       Impact factor: 1.271

4.  Increased incidence of neoplasia in females with acromegaly.

Authors:  N W Cheung; S C Boyages
Journal:  Clin Endocrinol (Oxf)       Date:  1997-09       Impact factor: 3.478

5.  Benign and malignant tumors in patients with acromegaly.

Authors:  J Barzilay; G J Heatley; G W Cushing
Journal:  Arch Intern Med       Date:  1991-08

6.  The prevalence of colonic polyps in acromegaly: a colonoscopic and pathological study in 103 patients.

Authors:  B Delhougne; C Deneux; R Abs; P Chanson; H Fierens; P Laurent-Puig; I Duysburgh; A Stevenaert; A Tabarin; J Delwaide; G Schaison; J Belaïche; A Beckers
Journal:  J Clin Endocrinol Metab       Date:  1995-11       Impact factor: 5.958

7.  Neoplastic colonic polyps in acromegaly.

Authors:  J Ortego; B Vega; J Sampedro; J Escalada; D Boixeda; C Varela
Journal:  Horm Metab Res       Date:  1994-12       Impact factor: 2.936

8.  Blockade of the insulin-like growth-factor-I receptor inhibits growth of human colorectal cancer cells: evidence of a functional IGF-II-mediated autocrine loop.

Authors:  H Lahm; P Amstad; J Wyniger; A Yilmaz; J R Fischer; M Schreyer; J C Givel
Journal:  Int J Cancer       Date:  1994-08-01       Impact factor: 7.396

9.  Increased epithelial cell proliferation in the colon of patients with acromegaly.

Authors:  A Cats; R P Dullaart; J H Kleibeuker; F Kuipers; W J Sluiter; M J Hardonk; E G de Vries
Journal:  Cancer Res       Date:  1996-02-01       Impact factor: 12.701

10.  Prevalence of colonic polyps is not increased in patients with acromegaly: analysis of 60 patients from India.

Authors:  Anil Bhansali; Rakesh Kochhar; Yogesh K Chawla; Somashekara Reddy; Radharaman Jiban Dash
Journal:  J Gastroenterol Hepatol       Date:  2004-03       Impact factor: 4.029

View more
  45 in total

Review 1.  Risk of Neoplasia in Pediatric Patients Receiving Growth Hormone Therapy--A Report From the Pediatric Endocrine Society Drug and Therapeutics Committee.

Authors:  Sripriya Raman; Adda Grimberg; Steven G Waguespack; Bradley S Miller; Charles A Sklar; Lillian R Meacham; Briana C Patterson
Journal:  J Clin Endocrinol Metab       Date:  2015-04-03       Impact factor: 5.958

Review 2.  Complications of acromegaly: thyroid and colon.

Authors:  Amit Tirosh; Ilan Shimon
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

3.  MTHFR C677T polymorphism, folate status and colon cancer risk in acromegalic patients.

Authors:  Maria Luisa Torre; Giuseppina T Russo; Marta Ragonese; Annalisa Giandalia; Ernesto De Menis; Giorgio Arnaldi; Angela Alibrandi; Carmelo Buda; Giovanni Romanello; Elisabetta L Romeo; Domenico Cucinotta; Francesco Trimarchi; Salvatore Cannavo
Journal:  Pituitary       Date:  2014-06       Impact factor: 4.107

4.  Adrenal lesions in acromegaly: do metabolic aspects and aryl hydrocarbon receptor interacting protein gene have a role? Evaluation at baseline and after long-term follow-up.

Authors:  F Ceccato; G Occhi; N M Albiger; S Rizzati; S Ferasin; G Trivellin; F Mantero; C Scaroni
Journal:  J Endocrinol Invest       Date:  2010-07-01       Impact factor: 4.256

5.  Predictors of colonic pathologies in active acromegaly: single tertiary center experience.

Authors:  Raim Iliaz; Sema Ciftci Dogansen; Seher Tanrikulu; Gulsah Yenidunya Yalin; Bilger Cavus; Mine Gulluoglu; Filiz Akyuz; Sema Yarman
Journal:  Wien Klin Wochenschr       Date:  2018-07-30       Impact factor: 1.704

6.  The effect of somatostatin analogs and acromegaly on the upper gastrointestinal system.

Authors:  Serdar Sahin; Tevhide Betul Icli; Emre Durcan; Cem Sulu; Hande Mefkure Ozkaya; Ali Ibrahim Hatemi; Pinar Kadioglu
Journal:  Pituitary       Date:  2020-10-19       Impact factor: 4.107

7.  Pituitary neuroendocrine tumors and differentiated thyroid cancer: do metabolic and inflammatory risk factors play roles?

Authors:  G Cortês Nascimento; A G P de Araujo Cortês Nascimento; C de Maria Ribeiro Veiga Parente; V P Rodrigues; R S de Sousa Azulay; V C de Carvalho Rocha; S da Silva Pereira Damianse; M Magalhães; M Dos Santos Faria; M B Gomes
Journal:  J Endocrinol Invest       Date:  2020-07-17       Impact factor: 4.256

8.  Usefulness of an ad hoc questionnaire (Acro-CQ) for the systematic assessment of acromegaly comorbidities at diagnosis and their management at follow-up.

Authors:  F Guaraldi; D Gori; G Beccuti; N Prencipe; R Giordano; Y Mints; V S Di Giacomo; A Berton; M Lorente; V Gasco; E Ghigo; R Salvatori; S Grottoli
Journal:  J Endocrinol Invest       Date:  2016-05-06       Impact factor: 4.256

9.  Obesity and colorectal cancer.

Authors:  Irena Gribovskaja-Rupp; Lauren Kosinski; Kirk A Ludwig
Journal:  Clin Colon Rectal Surg       Date:  2011-12

Review 10.  The role of colonoscopic screening in acromegaly revisited: review of current literature and practice guidelines.

Authors:  K Lois; J Bukowczan; P Perros; S Jones; M Gunn; R A James
Journal:  Pituitary       Date:  2015-08       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.